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THE products of combustion of tobacco consist of many thousands of com-
ponents and it is unlikely that any single one ofthese is responsible for the mouse
skin carcinogenic activity of whole smoke condensate. On the other hand, many
of the components fall into groups of structurally and chemically related com-
pounds and the biological activity of smoke could reside in a small number of
these groups. Several attempts have been reported, initially to separate the
carcinogenic from the inactive constituents of smoke and then to isolate groups of
related compounds from the most carcinogenic fraction to assess their relative
contribution to the total activity.
The mouse skin bio-assays of cigarette smoke condensate fractions published
to date have shown that the tumorigenic activity resides principally in a neutral
fraction, remaining after removal ofacids, phenols and bases (Wynder and Wright,
1957; Day, 1967). Also, activity was only found in sub-fractions of neutral
fraction which contained polycyclic aromatic hydrocarbons (PArH) (Wynder and
Hoffmann, 1959; Hoffmann and Wynder, 1966). Seelkopf, Ricken and Dhom
(1963) sub-fractionated neutral fraction by vacuum distillation and showed that
those fractions richest in PArH produced the most sarcomas when tested by s.c.
injection into rats. Similarly a sub-fraction of neutral fraction with the highest
activity in the Triton test was found to be that containing tri-, tetra-, penta-
and hexacyclic aromatic hydrocarbons (Bonnet and Neukomm, 1957; Neukomm,
1957). The importance of four-ring and five-ring aromatic hydrocarbons as
tumour initiators in the carcinogenic action oftobacco smoke condensate has been
emphasised by Wynder and Hoffmann (1968) in an article outlining the results of
testing 90 sub-fractions of neutral fraction.
Although some of the carcinogenic agents have been successfully concentrated
into a small number of fractions, quantitative assessment of the bio-assay results
has been complicated by the probability that the effect of condensate on mouse
skin is a two-step mechanism involving carcinogenic initiators and promotors.
Evidence for the occurrence of tumour-promoting agents in whole smoke con-
densate has been obtained by Gwynn and Salaman (1956), Hamer and Woodhouse
(1956) and Gellhorn (1958) and the results from tests on the acidic and nicotine-free
basic fractions were interpreted as an indication of the presence of promotors in
these fractions (Wynder and Wright, 1957). Wynder and Hoffmann (1961)
produced positive evidence that promotors are present in these fractions and they
confirmed the earlier finding of Roe, Salaman and Cohen (1959) of strong tumour
promoting activity in the phenolic fraction.
The method of preparing neutral fraction does not permit the recovery of all
the components of the whole smoke condensate (some 60-70% by weight being
recovered in the four sub-fractions, i.e. basic, acidic, phenolic and neutral).CARCINOGENICITY OF CIGARETTE SMOKE
Although it has been shown that the mouse skin tumour initiators and promoters
are concentrated to varying extents into the four sub-fractions, there continues to
be a discrepancy between the carcinogenic activity of the original whole smoke
condensate and the sum total of the activity of the recoverable fractions when
tested individually or in recombiniation.
It is not possible to determine whether the lower activity of neutral fraction
(Day, 1967) as compared with that of stored non-volatile whole smoke con-
densate (SWSC) is due to the destruction of initiators and/or promotors as a result
of using strong acid and alkali for the fractionation or to a failure to extract these
active compounds into neutral fraction by the teclhniques employed. This com-
munication describes an alternative procedure (Fig. 1) for the concentration of a
high proportion of the mouse skin carcinogens of SWSC into a single fraction by
the use of solvent partition methods.
The first stages (1 and la) involving the separation into water soluble (Fraction
B) and water insoluble material (Fraction C) and the subsequent extraction of
Fraction B with ether to produce Fraction E derived from a particular interest of
one ofus (J.K.W. unpublished work) in thepossibility offinding y and 8 unsaturated
lactones in tobacco smoke. Many naturally occurring lactones are water soluble
and can be extracted from aqueous solution withether. Mostchemnical carcinogens
which fall into other structural groups are insoluble in water.
In the second stage, the water insoluble fraction (C) is partitioned betwveen
cyclohexane and 9: 1 methanol: water, a solvent pair used by Grimmer (1962)
for the separation of neutrals from smoke condensate, and by Elmenhorst and
Grimmer (1968) as the first stage of a separation of PArH firom SWSC. The
partition coefficients of the PArH in this solvent system (Mold et al., 1963;
Whitehead and Rothwell, 1969, unpublished data) favour their extraction by the
cyclohexane phase. The majority of chemical carcinogens are lipophilic and
hence their concentration along with the PArH, in Fraction 0 would be expected
to occur.
Separation of polycyclic aromatic hydrocarbonsfrom cyclohexane fraction
Two fractionation schemes for the concentration of the PArH of cigarette
smoke into single sub-fractions of cyclohexane fraction (G) are shown in Fig. 2.
Scheme 1 was outlined in the Review of Activities (Tobacco Research Council,
1967) and involves three stages after the preparation of Fraction G: the removal
of urea-adductable constituents of Fraction G; the distribution of the non-
adductable material between cyclohexane and dimethyl sulphoxide (DMSO),
(Haenni, Howard and Joe (1962) showed that PArH are removed into the DMSO
phase) and the removal of non-PArH constituents of the DMSO-soluble material
(Fraction L) by adsorption on deactivated silica gel from benzene solution.
Whitehead and Rothwell (1969, unpublished data) have produced evidence from
radiochemical experiments with labelled PArH and from the determination of
distribution coefficients between the solvent systems used of a wide range of
PArH of differing molecular structure, that the fractionation scheme is likely to
concentrate all the unsubstituted PArH present in the original SWSC into the final
fraction (N).
The alternative separation (Scheme 2, Fig. 2) ofthe PArHfrom Fraction G was
the counter-current distribution of this material between cyclohexane and 9: 1
methanol : water. This stage results in the isolation of the three sub-fractions
68
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G2a, G1 and G2b having the distribution coefficient ranges: up to 2*5, from 2 5-6*1
and from 6K1-oo respectively. The published values (vide supra) for PArH between
thispair ofsolvents fall between 2 6 and 6*1 and, therefore, these compounds should
all be concentrated in Fraction GI. Furthermore, fractionation experiments on
condensate fractions containing trace quantities of six radioactively labelled
PArH of differing ring configurations resulted in recovery of virtually all the
radioactivity in Fraction Gl. Confirmatory results have been obtained in similar
experiments where a wide range of unsubstituted PArH added to the original
Fraction G could not be gas chromatographically detected in any fraction other
than GI.
Separation ofpolycyclic aromatic hydrocarbons from neutralfraction
Fractionation Scheme 3, shown in Fig. 3, shows an early attempt carried out
in these laboratories to concentrate the PArH of smoke condensate into a sub-
fraction of neutral fraction. The separation involves column chromatography of
neutral fraction to produce a PArH-concentrated sub-fraction HC produced by
exhaustive elution of an alumina column with benzene and a PArH-free sub-
fraction obtained by stripping the alumina with hot methanol. The PArH in the
hydrocarbon fraction (HC) are further concentrated in this scheme by the same
counter-current distribution technique between cyclohexane and aqueous meth-
anol as described for the third stage of fractionation Scheme 2.
MATERIALS AND METHODS
Cigarettes and smoking procedure.-Plain cigarettes (length 70 mm., circum-
ference 25-3 mm., average weight 1-09 g.) manufactured from a composite blend of
flue-cured tobacco representing the major plain cigarette brands smoked in the
United Kingdom were smoked in the automatic smoking machine described by
Day (1967) to the same standard smoking parameters.
Stored non-volatile whole smoke condensate (SWSC).-The cigarette smoke was
condensed in the same traps and the condensate so produced was treated and
stored in the same way as described by Davies and Day (1969).
Solvents.-The criterion of purity for all solvents other than acetone was that
on evaporating 1 litre to dryness under reduced pressure at not more than 100 C.,
the residue when dissolved in 1 0 ml. benzene should not show any materials
detectable by electron capture during gas chromatography of a 10 #u litre sample
under conditions in which 10-8 g. of benzo(a)pyrene would be detected (i.e
1 p.p.m. measured, equivalent to 1 part in 109 in the original solvent).
All solvents were fractionally distilled before use, cyclohexane and benzene
being washed with oleum (25% S03) and sulphuric acid respectively before
distillation. Petroleum ether (b.p. 40-60° C.) was passed down an alumina
column after distillation.
Fluorescent impurities were removed from anaesthetic grade ether with
sodium wire.
Preparation ofFractions
Fractionation Scheme 1 (Fig. 1 and 2)
Stage 1. Fractions B and C.-A suspension ofSWSC (20 g.) in acetone (25 ml.)
was poured, in small quantities, into distilled water (300 ml.) with shaking after
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each addition. Rapid cooling and vigorous shaking caused the insoluble material
to adhere to the flask and a clear yellow filtrate was obtained by filtration through
a wet, double, fluted filter (Whatman No. 1). The insoluble residue was treated
similarly twice using 12 ml. of acetone and 150 ml. of distilled water for each
further treatment.
Fraction B (yield 52*0% w/w SWSC) was recovered by freeze drying the
combined aqueous extracts and Fraction C (yield 45-3% w/w SWSC) was recovered
by dissolving the insoluble materials in acetone and evaporating the combined
solutions to constant weight, under reduced pressure, at not more than 100 C.
Stage la. Fractions D and E.-The bulked aqueous extracts were continuously
extracted with ether for 24 hours. The ethereal extract after drying (anhydrous
MgSO4) was evaporated below 100 C. to leave Fraction E. Yield 26.0% w/w
swsC.
Fraction D was recovered by freeze drying the residual aqueous solution.
Yield 26.4% w/w SWSC.
Stage 2. Fractions F and G.-Fraction C (from 20g. SWSC) in methanol
(180 ml.) was vigorously shaken with cyclohexane (200 ml.) and after dilution with
water (20 ml.) the shaking was continued. The phases were separated by centri-
fugation. Four further extractions ofthe lower phase with cyclohexane (200 ml.)
were carried out. Fraction G was recovered from the combined cyclohexane
extracts (yield 24.5% w/w SWSC) and Fraction F from the methanol by evapora-
tion to constant weight as above (yield 15-1% w/w SWSC).
Stage 3. Fractions H and J.-Fraction G (from 20 g. of SWSC) dispersed in
methanol (100 ml.) was shaken with urea (20 g.). The mixture was cooled from
250 C. to 00 C. (11-0 C. per hour) and kept at 00 C. overnight. After the mixture
had attained room temperature, aqueous saturated urea solution (12 ml.) was
added and the whole was extracted with cyclohexane (6 x 100 ml.), centrifuging
when necessary to break any emulsions formed. The cyclohexane solution was
dried (MgSO4) and the solvent removed at 100 C. under reduced pressure to leave
Fraction J (urea non-adductable). Yield 17.9% w/w SWSC.
The urea adduct and aqueous methanolic residue were mixed with hot water
(600 ml., 800 C.) and the mixture formed was extracted, after cooling, with
benzene (100 ml. aliquots) until colourless. The bulked benzene washings were
dried (MgSO4) and the solvent removed, as before, to leave Fraction H. Yield 5.3% w/w SWSC.
Stage 4. Fractions K and L.-Fraction J (from 20 g. SWSC) was disolved in
cyclohexane (30 ml.) and the solution was extracted with DMSO (4 X 20 ml.).
EachaliquotofDMSOwasthen washed successively with cyclohexane (3 X 10ml.).
Solvents were equilibrated before use. The combined upper phases were washed
with water (2 x 50 ml.), dried and evaporated as above to give Fraction K.
Yield 8 8% w/w SWSC. The combined lower phases were diluted with the
aqueous washings and distilled water (ca. 800 ml.) andthe solution, after saturation
with salt, was extracted with benzene (100 ml. aliquots) until colourless. The
benzene extract was dried and evaporated to give Fraction L. Yield 5-3% w/w
SWSC.
Stage 5. Fractions M and N.-Fraction L (from 20 g. SWSC) dissolved in
benzene (200 ml.) was shaken with silica gel (14 g.) (Koch-Light chromatographic
grade, 50-100 mesh, deactivated by adjusting the water content to 7-9% w/w).
After filtering and washing the gel with benzene (10 ml.), the volume ofthe filtrate
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and washings was reduced to 50 ml. under reduced pressure. The above procedure
was repeated with a further batch of silica (7 g.). Fraction N was recovered by
evaporation of the solvent from the combined benzene solutions and washings.
Yield 1 6% w/w SWSC. Fraction M was obtained by extraction of the silica gel
residues with methanol in a Soxhlet extractor. Yield 30 0% w/w SWSC.
Fractionation Schemne 2 (Fig. 2)
Stages 1 and 2. Fractions B, C, F and G. These fractions were prepared as in
Scheme 1.
Stage 3. Fractions G2a, GI and G2b.-A Quickfit and Quartz Steady State
Distribution Machine was modified so that extraction could be carried out simulta-
neously in each oftwo 51 tube trains. The solvent pair was made by equilibrating
cyclohexane with 9: 1 methanol: water, the water being half saturated with
AnalaR sodium chloride. The work was carried out in a temperature controlled
room at 20° C.
Fraction G (35 g.) dissolved in upper phase (175 ml.) was charged in tubes 0 to
-6 in each tube train numbered as follows:
delivery of delivery of
upper phase (+8 to +1) (O to -6) (-7 to -42) lower phase
from machineJ Lfrom machine
The machine was programmed to carry out 614 transfers, delivering 25 ml. of
upper phase and 25 ml. oflower phase in opposite directions in the ratio of 2 upper
phase transfers to 11 lower phase transfers. All the upper phase delivered from
the machine was collected in a single receiver and the lower phase from transfers
0-319 and from 320-614 in separate receivers. The residues were recovered from
the lower phase, after the methanol had been removed, by extraction into cyclo-
hexane which was then washed with water dried (MgSO4) and evaporated to
constant weight. Upper phase was washed with water, dried (MgSO4) and the
residue recovered by evaporating off the solvent. The sub-fractions collected
were made up as follows:
G2a Lower phase ejected during transfers 0-319.
This fraction contained all the material within the distribution
coefficient range 0-2-50 with a proportion of material from 2-5-2-75 and
the yield was 4.9%0 w/w SWSC.
GI Material remaining in tubes +7 to -42 after 614 transfers and lower
phase ejected during transfers 320-614.
This fraction contained all the material within the distribution
coefficient range 2-75-6-06 with some material from 2-5-2-75 and from
6-06-6-58. The yield was 2.10% w/w SWSC.
G2b The contents oftubes +8 and 9 and the upper phase ejected during trans-
fers 0-614. This fraction contained all the material within the distribu-
tion coefficient range 6 58-oo with some material from 6 06-6 58 and the
yield was 14.3% w/w SWSC.
Two sub-fractions were tested by mouse painting: G1, the sub-fraction containing
all the unsubstituted PArH of Fraction G, and G2 (the sum of G2a and G2b) the
PArH-free sub-fraction.
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Fractionation Scheme 3 (Fig. 3)
Stage 1. Neutral fraction.-This fraction was prepared from SWSC by the
method of Day (1967).
Stage 2. Hydrocarbonfraction (HC). Neutral fraction (15 g.) (Day, 1967 was
dissolved in petroleum ether (b.p. 40-60° C.) and applied to a column (4 cm. diam.)
of alumina (300 g. Neutral Woelm, Activity 1). The column was developed with
petroleum ether until no further fluorescence appeared in the eluate (ca. 1000 ml.).
Development was continued with benzene until no fluorescence (detected under
u.v. light) remained on the column (ca. 1500 ml.). The combined eluates were
evaporated to dryness. Yield of hydrocarbon fraction was 6 3% w/w SWSC.
Stage 3. Fractions HC2a, HC1 and HC2b.-The equipment, conditions,
solvents and programme were the same as for the preparation of Fractions G2a,
Gl and G2b (Stage 3 of Fractionation Scheme 2), except that 17-5 g. of hydro-
carbon fraction (HC) was used for each separation. The yields of products were:
HC1, 0.25% w/w SWSC and HC2, 4.2% w/w SWSC.
Animal Experiments
Mice.-Female, albino mice of a specific pathogen-free strain were obtained
from the Pharmaceuticals Division, Imperial Chemical Industries Ltd., at 4-6
weeks of age.
Mice were housed, three in a box, in sterilised galvanised iron boxes containing
sterilised sawdust. Mice in each box were identified by ear punching. They were
fed pasterurised Oxoid Breeding Diet pellets and provided with drinking water in
sterilised bottles ad libitum.
Mice were randomly allocated to the different experiments in the numbers
indicated in Table I.
Dosimetry and skin application procedures
Solutions of whole smoke condensate or the fractions therefrom were applied
thrice weekly on Monday, Wednesday and Friday by means of a foot operated
automatic pipette delivering a volume of 0-3 ml. to an area of dorsal skin 1-5 cm.
wide extending from the nape of the neck to the base of the tail. The hair was
shaved withelectric clippersbeforethefirst application and subsequently atweekly
intervals throughout the entire life of the animal.
Details of weekly equivalent doses and the solvents used for making up the
treatment solution for each experiment are given in Table I. All doses are
expressed in terms of stored non-volatile whole smoke condensate equivalent
weights, mg./wk (equiv. dose), i.e. in the case of fractions, the amount of non-
volatile whole smoke condensate required to yield the actual amount of fraction
applied per week per mouse.
Post-mortem and histopathology
Full post-mortem examination was performed on all mice (except in cases
where autolysis was too advanced) which died during the night, appeared irre-
coverably ill, or on tumour bearing animals when the tumour appeared malignant
as judged by the apparent attachment of the tumour to deeper structures of the
back.
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TABLE I.-Details of Mouse Painting Experiments
Experi-
ment
no. I Material
1 . Whole smoke condensate
2 . Fraction B
Fraction C
Fractions B + C
3 . Fractions D + E + C
4 Fraction D
5 Fraction E
Fraction F
Fraction G
Fraction D+E+F+G
6 . Whole smoke condensate
Fraction N
Neutral Fraction
Fraction N
FractionE+F+H+K+M.
7 . Whole smoke condensate
Fraction H
Fraction K
Fraction M
Fraction M
8 . Whole smoke condensate
Fraction G
Fraction Gl
Fraction G2
Fraction GI + G2
9 . Whole smoke condensate
Fraction HC
Fraction HC1
Fraction HC2
Fraction HC1+HC2
No. of
mice
240
300
300
300
300
400
390 .
390
390
390
198
171
198
171
102
165
150
150
171
171
198
198
198
198
198
198
198
198
198
198
Weight of
material
applied
(mg./wk)
300
156
136
298
291
127
125
72
113
109
300
4.7
198
9-4
343
300
32
53
9
18
300
73
6
58
63
300
19
0-75
12*6
13*3
Equivalent
dose
(SWSC)
(mg./wk)
300
300
300
300
300
480
480
480
480
120
300
300
600
600
600
300
600
600
300
600
300
300
300
300
300
300
300
300
300
300
Solvent used
Acetone/water 9: 1
Acetone/water 9: 1
Acetone/water 9: 1
Acetone/water 9: 1
Acetone/water 9: 1
Acetone/water 7: 3
Acetone/water 9: 1
Acetone/water 9: 1
Acetone/ether 9: 1
Acetone/water/ether 35 5 1
Acetone/water 9: 1
Acetone/ether 7: 3
Acetone/water 9: 1
Acetone/ether 7: 3
Acetone/water/ether 20 2 3
Acetone/water 9: 1
Acetone/ether 7: 3
Acetone/ether 7: 3
Acetone/water 8: 2
Acetone/water 8: 2
Acetone/water 9: 1
Acetone/ether 7: 3
Acetone/ether 7: 3
Acetone/ether 7: 3
Acetone/ether 7: 3
Acetone/water 9: 1
Petroleum ether/acetone 7: 3
Petroleum ether/acetone 7: 3
Petroleum ether/acetone 7: 3
Petroleum ether/acetone 7: 3
Histological preparations of all skin tumours, an area of painted skin, and any
other organ which appeared macroscopically abnormal at post-mortem examina-
tion were examined.
RESULTS
In comparing the carcinogenicity ofdifferent materials, the age standardisation
analysis of Lee (1969, unpublished data) has been applied to compensate for
differing mortality rates occurring in various treatments. Deviations in mortality
rates were only appreciable with smoke materials containing nicotine or in those
experiments involving high dose levels. Table II to V show the results of the
mouse painting experiments testing the fractions obtained from the various
stages of fractionation Scheme 1. Table VI gives the results of testing Fractions
GI and G2 prepared in stage 3 of fractionation Scheme 2. Table VII gives the
results from testing fractions from stage 3 of fractionation Scheme 3.
Fractionation Scheme 1
Stages 1 and la (Tables II and III).-The results showed that Fraction B, the
water soluble material (52% of SWSC) contains only a very small proportion of
the carcinogens ofwhole smoke condensate. This active material is not removed
by continuous extraction of the aqueous smoke solution with diethyl ether as the
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TABLE II.-Results ofSkin Painting Experiments Testing Fractionsfrom
Stage 1 ofFractionation Schemes 1 and 2
Standardised Standardised
Weight percentage tumour percentage carcinoma
distribution as Equivalent bearing animals bearing animals
Experi- percentage dose with 95% with 95%
ment Fraction SWSC (mg./wk) confidence limits confidence limits
1 . SWSC . 100 . 300 . 38 0 (32.0-44 2) . 22.5 (17.5-28.0)
2 . C 45.3±3-0 300 . 32.3 (27.1-37.7) . 14.9 (11-1-19.1)
2 . B+C 97-4±2-7 300 . 35.3 (30-0-40 8) . 19-7 (15.5-24-5)
Weight loss in separation (A-B-C) 2-6 ± 2i 7% w/w SWSC
2 . B . 52-0±3-2 . 300 . 2-7 (1.2-4-8) . 0-9 (0.2-2.3)
Experi
ment
1
3
4
5
TABLE III.-Results ofSkin Painting Experiments Testing Fractions
from Stage la ofFractionation Scherme 1 (Fig. 1)
Standardised Standardised
Weight percentage tumour percentage carcinm
distribution Equivalent bearing animals bearing animal,
as percentage dose with 95% with 95%
Fraction SWSC (mg./wk) confidence limits confidence limit
SWSC . 100 . 300 . 38 0 (32-0-44- 2) . 22-5 (17-5-28-(
D+E+C . 96-7±2-5 . 300 . 37-7 (32-3-43-3) . 20-1 (15-8-24-}
Weight loss in separation (A-D-E-C)=3-3±2-5% w/w SWSC
D . 26-4±3-1 . 480 3-1 (1-6-5) 0-6 (0-1-1-6)
E . 26-0±2-4 . 480 . 0-4 (0-1-3) 0 (0-0-2)
oma
Is
ts
O)
8)
ethereal extract (Fraction E, is inactive) and the aqueous residue, Fraction D
retains the activity of the original aqueous solution, Fraction B.
The water insoluble Fraction C when painted at 300 mg./wk gave 32% tumour
bearing animals as against 38% by whole smoke condensate at the same dose level.
Slightly fewer animals produced carcinomas with this material than with SWSC
(15% as against 22%).
The separations were efficient both with respect to the small weight losses-an
average of 2-6% in the separation into Fractions B and C and 3-3% into Fractions
D, E and C-and with respect to small loss ofbiological activity. The recombina-
tions B + C (Experiment 2) and D + E + C (Experiment 3) gave the same
activities in the production of both tumour and carcinoma bearing animals as the
SWSC.
Stage 2 (Table IV).-Experiments 5 and 8 showed that a very high proportion
of the carcinogenic constituents of SWSC are extracted by cyclohexane (Fraction
Expe;
men
8
8
6
5
5
5
TABLE IV.-Results ofSkin Painting Experiments Testing Fractionsfrom
Stage 2 of the Fractionation Schemes 1 and 2
Standardised Standardise
Weight percentage tumour percentage carcii
distribution Equivalent bearing animals bearing anims
ri- as percentage dose with 95% with 95%
it Fraction SWSC (mg./wk) confidence limits confidence lim
SWSC . 100 . 300 . 50 - 8 (43- 8-57 7) . 26-7 (20- 8-33
G 24-5±1-2 . 300 . 45-9 (39-0-52 9) . 23-4 (17-8-29
Neutral . 32-6±1-6 . 600 . 53-6 (46-6-60-5) . 36-0 (29-5-42
d
.noma
als
iits
I-0)
-6)
-8)
Fraction
G . 23-6±1-6 . 480 . 57-0 (52-0-61-9) 33-4 (28-8-38-2)
F . 15-1±1-2 . 480 . 2-2 (1-0-3-9) - -
Combined weight loss in Stages 1, la and 2 (A-D-E-F-G)=9-0% w/w SWSC
. D+E+F+G . 91-0 . 120 7-3 (4-9-10-1) 1-8 (0-7-3-3)
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G) from an aqueous methanolic solution of the water insolubles. The methanol
fraction (F) produced only 2% tumour bearing animals and none with carcinomas
when tested at 480 mg./wk, whereas the cyclohexane Fraction G produced 57%
tumour and 33% carcinoma bearing animals at the same dose level.
Only marginal loss ofactivity during the preparation ofFraction G is shown by
the direct comparison of both tumour and carcinoma production by SWSC and by
Fraction G. A comparison of Fraction G with neutral fraction offers an indirect
confirmation that the former retains almost all of the activity of the original
condensate. Day (1967) showed that neutral fraction exhibits 80% ofthe activity
of SWSC yet only at 600 mg./wk (equiv. dose) can it achieve the activity of
Fraction G at 480 mg./wk (equiv. dose). Similarly, although there is no direct
comparison of the carcinogenicity of the recombined Fractions D + E + F + G
with SWSC at the same dose level, the fact that 7 3% of the animals treated with
the recombined material at 120 mg./wk (equiv. dose) produced tumours compared
with 5.3% of those treated with SWSC at 75 mg./wk and 11.6% at 150 mg./wk
(Day, 1967) confirms that very little loss of biologically active material occurred.
Finally, in recent but at present incomplete experiments, SWSC, Fraction C,
Fraction F + G and Fraction G tested at the same dose level on mice from the
same delivery are all giving similar numbers of animals with tumours.
Stages 3 to 5 (Table V).-In Experiments 6 and 7 the PArH-free Fractions H,
K and M and Fraction N into which the PArH had been concentrated were tested.
TABLE V.-Results of Skin Painting Experiments Testing Fractions from
Stages 3-5 ofFractionation Scheme 1
Standardised Standardised
Weight percentage tumour percentage carcinoma
distribution Equivalent bearing animals bearing animals
Experi- as percentage dose with 95% with 95%
ment Fraction SWSC (mg./wk) confidence limits confidence limits
6 . SWSC (A) . 100 . 300 41-1 (34.4-48.0) 27-3 (21.3-33.7)
6 . Fraction N 1-6±0-3 . 300 5-2 (2-4-9.0) . 1-2 (0.1-3 4)
6 . Neutral 32-6+1-6 . 600 . 53-6 (46-660.5) 36 0 (29 5-42 8)
Fraction
6 . Fraction N 1-60-3 . 600 . 22-3 (16 4-28-8) 9-4 (5-514-2)
Weight loss in separations (G-H-J)=2 0±1-0% w/w SWSC and (J-K-L)=2-0±1-3% w/w SWSC
7 SWSC (A) . 100 . 300 53.2 (45-6-60.7) 26-8 (20 4-33 8)
7 Fraction M . 3 00 2 . 300 . 2-1 (0.5-4.8) 00 (0 0-06)
Weight loss in separation (L-M-N) 1-12+0- 8% w/w SWSC
7 . Fraction H 53±0.8 . 600 13-7 (86-19-6) . 3-4 (11-6.9)
7 . Fraction K 8-90-8 . 600 4-7 (1-98-7) . 07 (00-2.7)
7 . Fraction M . 3-0±02 . 600 3-2 (1.1-6.3) . 12 (0.1-3.4)
7 . Fractions E 57-3 . 600 . 20.0 (12.8-28-3) . 17-6 (10.9-30.3)
F+H+K+M
Fraction N was the only material to show significant tumorigenicity but this
activity (5-2% tumour and 1.2% carcinoma bearing animals at 300 mg./wk
(equiv. dose)) was considerably less than that of SWSC (41-1% and 27-3% re-
spectively at 300 mg/wk (equiv. dose)) or of neutral fraction (53.6% and 36-0%
respectively at 600 mg./wk (equiv. dose)). Fractions K and M showed insignifi-
cant activity and Fraction H, a small but significant activity (13X7% tumour and
3.4% carcinoma bearing animals at 600 mg./wk (equiv. dose)). The combined
PArH-free fractions E + F + H + K + M gave results of 20-0 / animals with
tumours and 17.6% with carcinomas at 600 mg./wk (equiv. dose).
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Fractionation Scheme 2
Stage 3 (Table VI).-Sub-fraction GI, the material of distribution coefficient
range 2-5-6-1 isolated by counter-current extraction from Fraction G and con-
taining all the unsubstituted PArH was tested in Experiment 8. The other
TABLE VI.-Results ofSkin Painting Experiments Testing Fractionsfrom
Stage 3 of the Fractionation Scheme 2
Standardised Standardised
Weight percentage tumour percentage carcinoma
distribution Equivalent bearing animals bearing animals
Experi- as percentage dose with 95% with 95%
ment Fraction swsC (mg./wk) confidence limits confidence limits
8 . GI . 2.1+0.4 . 300 . 76 (4.3-11.7) . 14 (0.2-3.4)
8 . G2 . 19*2±2-3 300 . 28-2 (22 2-34 7) . 73 (4.1-11*4)
8 . G1+G2 20-9+1-4 300 . 35 0 (28 5- 41-8) 10.9 (6.9-15.6)
8 . G . 24*5±1-2 . 300 . 45.9 (39.0-52.9) 23-4 (17.8-29.6)
8 . SWSC (A) . 100 300 . 50*8 (43.8-57-7) . 26.7 (20 8-33-0)
Weight loss in separation (G-G1-G2)=13 6±6-2% w/w Fraction G or 3.4+1I5% w/w SWSC
constituents of Fraction G (material with KA = 0-2*5 and KA = 6 1-00) were
isolated into sub-fraction G2 and also tested in this experiment. The PArH
enriched fraction (GI) produced only 7.6% tumour and 1.4% carcinoma bearing
animals compared with 28-2% and 7-3% respectively for the PArH-free fraction,
G2, tested at the same dose level 300 mg./wk (equiv. dose).
The recombined fractions, Gl + G2, gave 35% tumour bearing animals as
compared with 46% for the original Fraction G, showing that there is a minor loss
of active material.
Fractionation Scheme 3
Stage 2 (Table VJJ).-The hydrocarbon fraction, containing all the PArH of
whole smoke and isolated from neutral fraction by column chromatography on
alumina, when tested for mouse skin carcinogenicity in Experiment 9 at 300 mg./
wk (equiv. dose), produced 18*7% tumour bearing animals as comparedwith50 7%
by SWSC atthe same doselevel, in Experiment 8. These experiments were carried
out at the same time on mice from the same delivery and thus the results are
directly comparable.
Stage 3 (Table VJJ).-The PArH-enriched fraction (HCI) representing 0.25%
w/w of SWSC gives 6.8% tumour bearing animals and the PArH-free fraction
TABLE VIJ.-Results ofSkin Painting Experiments Testing Sub-fractions
ofNeuttral Fraction Obtained by Counter-current Extraction Scheme 3
Standardised Standardised
Weight percentage tumour percentagecarcinoma
distribution Equivalent bearing animals bearing animals
Experi- as percentage dose with 95% with 95%
ment Fraction SWSC (mg./wk) confidence limits confidence limits
9 . HCI . 0-25±0*09 . 300 . 6-8 (3-7-10.7) . 00 (0-0-0.5)
9 . HC2 . 4-19+0 74 . 300 . 85 (5.0-12.8) 12 (0-2-3.2)
9 . HC1+HC2 . 4444+0 72 300 . 18.0 (13.1-23.8) . 35 (1.4-695)
9 . HC . 6-29+1-0 . 300 . 18-7 (13.6-24.4) . 49 (2.4-8.3)
9 . SWSC (A) . 100 . 300 . 50.7 (43.8-57-7) . 26.5 (20 6-32 8)
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(HC2) representing 4.2% w/w of SWSC gives 8.5% at 300 mg./wk (equiv. dose).
Whilst there is a considerable weight loss during this fractionation (39%) the
activity of the recombined fractions (HC1 + HC2) is not significantly different
from that of the original hydrocarbon fraction.
Examination of tissues other than skin
Histopathalogical studies of tissue sections other than those derived from skin
showed no difference in the incidence of tumours or other disease processes in any
of the treated mice when compared with untreated control mice housed under
identical conditions.
DISCUSSION
A review ofthe literature shows that the examination ofthe biological activity
of smoke condensate has mainly centred on neutral fraction and evidence has
accumulated to implicate the PArH as tumorigenic initiators in smoke. None of
the work on neutral fraction to date has shown a mouse skin tumorigenicity for
this material greater than 80% of the activity of whole smoke condensate. Also,
the missing activity is neither apparent in the other recovered fractions, nor can
it be reconstituted by combination of all the fractions (Wynder and Hoffmann,
1967).
The present work shows that the fractionation Schemes 1 and 2 described above
do not incur similar losses of active material. A high recovery ofthe carcinogens
of SWSC into the cyclohexane fraction (G) is shown by comparison of the results
from testing the two materials in Experiment 8. Furthermore, the tumour yield
from a 600 mg./wk (equiv. dose) of neutral fraction in Experiment 6 is achieved
by a 480 mg./wk (equiv. dose) of Fraction G in Experiment 5. In view of these
and later confirmatory results, Fraction G, representing 25% w/w of SWSC as
compared with about 35% w/w for neutral fraction, and containing a higher pro-
portion ofthe original activity, is clearly the more satisfactory material for further
fractionation.
The low activity, in terms of both tumour and carcinoma bearing animals, of
the water soluble material from smoke condensate is not significantly different
(95% confidence limit) from untreated or solvent controls in our experiments, a
result which is not surprising in view ofthe fact that few water soluble mouse skin
carcinogens are known. However, that even this low activity cannot be detected
in the ethereal extract (Fraction E) would appear to exclude the possibility of
simple carcinogenic unsaturated y or 8 lactones of the type found in some plants
(Dickens and Jones, 1961) being present in tobacco and passing unchanged into
cigarette smoke. The numbers of tumour bearing animals produced by the
recombined water soluble (B) and water insoluble (C) fractions were just signi-
ficantly greater than those from Fraction C alone after 48 weeks and 64 weeks but
the differences reduced to insignificance towards the end of the experiment. The
number of carcinoma bearing animals was significantly greater for the recombined
fractions from 64 weeks onwards. These results suggest that some of the water
soluble constituents may act as promoting agents. This interpretation would
agree with the finding ofearlier workers (Roe et al., 1959; Wynder and Hoffmann,
1961) that the recoverable fractions other than neutral fraction show promoting
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activity, as some 80% w/w of these latter fractions have been found to be water
soluble in our own work. It has been suggested (Demisch and Wright, 1963) that
the material responsible for the low tumorigenic activity of the acidic fraction
recovered from the alkaline extract of smoke condensate might be PArH solu-
bilised by a mechanism comparable with the solubilisation of hydrocarbons by
alkaline solutions of desoxycholic acid. A similar mechanism might afford an
alternative explanation for the very low tumorigenic activity in Fraction B. The
results ofExperiments 2, 5 and 8 show that, apart from the relatively insignificant
tumorigenic material extracted into Fraction B and the even smaller amount
extracted in Fraction F, nearly all the carcinogens ofwhole smoke condensate pass
into Fraction G via Fraction C.
Considerable interest has been centred in the PArH present in tobacco smoke
condensate, partly because ofthe known carcinogenic properties ofsome members
of this group of compounds and, because in the work to date, the fractions con-
taining the recovered activity have been those in which PArH have been con-
centrated (loc. cit.). Wynder and Hoffmann (1968) state that " Tumour initiating
activity was found essentially only for those sub-fractions which contain four and
five-ring aromatic hydrocarbons. The data now available warrant the conclusion
that cigarette smoke contains more types of polynuclear aromatic hydrocarbons
than have so far been identified. A significant part of the initiating activity of
tobacco tar is certainly due to the presence of such hydrocarbons " and they
suggest that hydrocarbons of the chrysene type, and derivatives thereof, account
for a significant proportion of this activity.
Sub-fractionation of Fraction G involving the stages of urea adduction, distri-
bution between cyclohexane and dimethyl sulphoxide and adsorption with de-
activated silicagel (Scheme 1, Fig. 2) yielded a sub-fraction (N) which, it is thought
with some certainty from radiochemical evidence, should contain all the three-,
four- and five-ring PArH and probably the larger members of the group. The
results given in Table V show that Fraction N is the only fraction with significant
activity: a result which appears to confirm Wynder and Hoffmann's observations
given above. However, this activity is equivalent to no more than 12% of that
given by SWSC when both are tested at 300 mg./wk (equiv. dose) and even at
double this dose, 600 mg./wk (equiv. dose), Fraction N only produces half the
tumouryield of SWSC (at 300 mg./wk (equiv. dose)). Fractions K and M showed
only little activity and Fraction H showed a small but significant activity.
These results can be explained in two ways:
1. Considerable amounts of carcinogenic constituents of SWSC are lost in the
three stages of separation between Fractions G and N.
2. Initiators and promotors are present in Fraction G and in the subsequent
fractionation procedures the promoters are removed into one or all of the
Fractions H, K or M whilst the initiators, included amongst which are the
PArH, pass through to Fraction N. That the recombined Fractions E +
F + H + K + M (the PArH-free fractions except D) gave an increased
incidence of both tumour bearing animals and moreparticularly carcinoma
bearing animals over the only fraction (H) to give a significant activity
in both respects when tested alone, might be explained by the separation
of promoting material in one or more of these fractions other than
Fraction H.
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These possibilities are being examined in a comprehensive series of mouse skin
painting experiments in which all the fractions in Scheme 1 from SWSC through to
Fraction N are being tested individually and in recombination. Full details of
this work will be published when complete, but results after 64 weeks already
strongly indicate that there is no major loss of tumorigenic activity up to and
including the separation ofFraction L. Furthermore, those tests which duplicate
earlier work (Table V) are giving the same results at the same stage ofthe experi-
ments. The recombined fraction, M + N, tested at 600 mg./wk (equiv. dose)
after 56 weeks, has produced 10-8% animals with tumours and the recombined
fraction, H +K +M +N, has produced 11.8% compared with 12.8%, 29.3%
and 31*3% for Fractions N, L and G respectively, tested alone at the same dose
level. These results, even at this early stage of the experiments show that con-
siderable losses have occurred in the final stage (5) of the separations. It is
thought that carcinogens other than PArH are irreversibly adsorbed on, or
catalytically destroyed by the silica gel.
A similar loss of activity is shown in the results from tests on the hydrocarbon
fraction (HC) and SWSC. In all our experiments at 300 mg./wk (equiv. dose),
neutral fraction has produced 70-80% the yield ofanimals with tumours produced
by SWSC at this level. The hydrocarbon fraction produced only 30% of the
tumour bearing animal yield of SWSC although the fraction contained all the
PArR of smoke. The further concentration of PArH by counter-current extrac-
tion into sub-fraction HCI produced material having the same activity as the
PArH Fraction N produced by a totally different method.
The direct application of the counter-current extraction technique to Fraction
G (Scheme 2, Fig. 1) results in the concentration of unsubstituted PArH into sub-
fraction GI which has similar activity to that ofthe two other PArH-rich fractions,
N and HC1, the yields of tumour bearing animals being 7.6 /, 6.8% and 5.2% for
Fractions GI, HCI and N respectively. In this separation, however, the PArH-
free sub-fraction, G2, is considerably more active (28.2% tumour bearing animals)
than the PArH-rich fraction, GI, a result which contrasts with those from other
schemes. It seems likely that virtually all the biologically active material in
sub-fraction G2 is lost in the alternative separation scheme between Fractions L
and N and a high proportion of it is lost in the separation of the hydrocarbon
fraction (HC) from neutral fraction. This active material appears to be irre-
versibly adsorbed on silica gel and when adsorbed on alumina it is only possible to
elute a proportion of the residue, left after removal ofhydrocarbon fraction, with
methanol. In one experiment this material when tested by mouse painting gave
half the percentage of animals with tumours given by the hydrocarbon fraction.
The tumouryield from the recombined Fractions GI and G2 was 35% as compared
with 45-9% for the original Fraction G (Table VI), indicating that the overall loss
of active material in the separation is not high.
The low biological activity ofthe three fractions containing PArH (N, HC1 and
GI) has led to the consideration of groups of chemical carcinogens, other than
PArH, which might conceivably contribute to the biological activity of tobacco
smoke condensate. A few members of two such groups of compounds, closely
related to the PArH, namely alkyl substituted aromatic hydrocarbons and
heteropolycycic aromatic compounds, have been detected in smoke condensate
(e.g. Grob, 1965, 1966, and Van Duuren et al., 1960). As a result of the deter-
mination ofthe distribution coefficients of a wide range ofboth types ofcompound
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between the solvent pairs used (Whitehead and Rothwell, 1969, unpublished data)
it has been found that most of these would not have been isolated in the PArH-
enriched Fraction HC1 or Gl. Methyl derivatives of PArH have distribution
coefficients similar to those of the parent compounds but substitution with higher
molecalar weight alkyl groups raises the values, so that these higher homologues
if present in condensate, would be extracted in Fractions G2b and HC2b. Con-
versely, the majority of the nitrogen-heteropolycylic compounds, having low
distribution coefficients would be extracted in Fractions G2a and HC2a. Sub-
fractions ofG2a and G2b are at present being tested for mouse skin carcinogenicity
to determine, more precisely, the distribution coefficient range in which the non-
PArH carcinogenic constituents are to be found.
SUMMARY
1. Three fractionation schemes are described for the concentration of the
polycyclic aromatic hydrocarbons (PArH) of cigarette smoke condensate.
2. Schemes 1 and 2 have their first two stages in common which result in the
separation of cyclohexane soluble material (Fraction G), representing 24% by
weight ofthe original smoke condensate, from water soluble and methanol soluble
constituents.
3. The mouse painting tests show that by direct comparison Fraction G
contains a very high proportion of the tumorigenic components of stored non-
volatile whole smoke condensate (SWSC). Neutral fraction (33-35% w/w
SWSC) at 600 mg./wk (equiv. dose) gives a similar number ofboth tumour bearing
animals and carcinomabearing animals as Fraction G (24% w/w SWSC) at 480 mg./
wk (equiv. dose). Fraction G is considered to be the more satisfactory material
for further attempts to isolate the mouse skin carcinogenic factors in whole smoke
condensate.
4. Fractions N, GI and HC1, the materials containing the PArH in most
concentrated forms so far tested for biological activity, produced similar numbers
of animals with tumours in each case.
5. In fractionation Scheme 1 considerable losses of carcinogenic material,
which are not reflected in losses ofPArH, occur during the last three stages ofthe
separation. Recent work indicates that this loss occurs by irreversible adsorption
or catalytic destruction of biologically active material on silica gel. Similar, but
less pronounced, losses were encountered in the preparation of hydrocarbon
fraction from neutral fraction (Scheme 3) by the partially irreversible adsorption
or destruction of biologically active material on alumina.
6. Scheme 2 gave some loss of biologically active material but this was not
appreciable. Whereas Fraction GI, containing all the PArH, proved to be as
active as Fractions N andHC1, its activity wasonly one-quarter ofthat ofFraction
G2, the recovered PArH-free material and one-sixth ofthe activity ofwhole smoke
condensate.
7. There was no effect on the incidence ofspontaneously occurring tumours or
disease processes in any ofthe treated groups as compared with untreated control
mice housed under identical conditions.
8. The general conclusions drawn from this work are that solvent partition
methods for the fractionation ofSWSC are highly satisfactory in minimising losses
of biologically active material and that the unsubstituted polycylic aromatic
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hydrocarbons are probably not such important carcinogenic constituents of
cigarette smoke condensate as has been thought hitherto.
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